Each site that works with Probity Medical Research (PMR) is owned and operated by specialists who run large community based practices with a constant influx of patients in their therapeutic specialty.
PMR Highlights
- Over 50 clinical research facilities in Australia, Canada, Chile, Mexico and the United States
- Experience in Phase I, II, III, and IV clinical trials
- Investigators have conducted more than 500 unique clinical trials
- Over 15,000 patients followed in those trials
- Consistently the top enrolling sites
- Responsible for driving the subject recruitment timelines in many studies resulting in earlier submissions to regulatory authorities
- High quality data as evidenced by 17 regulatory inspections (FDA, Health Canada, & EMEA) with no significant findings
- Key opinion leaders (KOL) who have consulted on compound development for over 55 pharmaceutical companies
- Contribute to and guide protocol development for realistic and feasible studies
- Present clinical data due to vast experience with products that are developed
- Authorship
- New England Journal of Medicine
- American Journal of Cardiology
- American Journal of Hematology
- Annals of Internal Medicine
- Arthritis & Rheumumatism
- Australasian Journal of Dermatology
- British Journal of Dermatology
- British Journal of Urology International
- Canadian Journal of Gastroenterology
- Clinical Infectious Diseases
- Clinical Lymphoma
- Cutis
- European Urology
|
- Lancet
- Gastroenterology
- Gastrointestinal Endoscopy
- Human Molecular Genetics
- International Journal of Radiation Oncology Biology Physics
- Journal of Cutaneous Medicine and Surgery
- Journal of Allergy and Clinical Immunology
- Journal of American Medical Association
- Journal of the American Academy of Dermatology
- Journal of the European Academy of Dermatology and Venereology
- Journal of Urology
- Journal Rheumatology
- Medical Journal of Australia
- Modern Medicine
- Ophthalmology
- Pediatrics
- Urology
|